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Key points: 
 PVC is important for accurate quantification in PET and for avoiding confounding factors 
related to changes in PVE, but is currently not routinely used in clinical practice.  
 Co-registered anatomical information from MRI can be utilised for accurate PVC of PET data.  
 Anatomically guided correction for PVE can be performed as a post-reconstruction 
procedure or during the image reconstruction process.  
 The introduction of PET/MRI scanners could facilitate the use of PVC in routine clinical 
studies.  
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Synopsis: 
Partial volume effects (PVEs), are caused by the limited spatial resolution of the PET system, which 
results in a blurry appearance of the PET images and a reduction in the observed activity for small 
objects. There is increasing evidence that partial volume correction (PVC) is necessary in order to 
guarantee quantitative accuracy in PET. However, there is reluctance to apply PVC routinely in 
clinical practice, partly due to uncertainty regarding the method of choice.  
In order to perform accurate PVC, it is necessary to introduce information from high-resolution 
anatomical images, such as CT or MRI. A number of correction methods have been developed in the 
past; either post-reconstruction or reconstruction-based methods. The latter can be more accurate, 
but the former are easier to implement. All the methods rely on accurate co-registration between 
the anatomical image and the PET image. PET/MRI offers clear advantages for PVC and can help 
alleviate the image registration issues.  
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Introduction 
Partial volume effects (PVEs), are caused by the limited spatial resolution of the PET system, which 
results in a blurry appearance of the reconstructed PET images, and as a consequence a reduction in 
the observed maximum activity for small objects (1) (see Box. 1). Partial volume correction (PVC) is 
essential for accurate quantification in PET, especially in small objects. PVC can also be important in 
situations when the PVE changes over time or between subjects (see Box 2).  
PVEs can be regarded as two separate effects: spill-out of data from inside an image region and spill-
in of data from outside into the region. The amount of spill-over between regions depends on the 
point-spread function (PSF) of the imaging system, which is often modelled as a 3D Gaussian 
function, characterised by its full-width at half-maximum (FWHM) – the larger the FWHM, the larger 
the spill-over. The blurring of the reconstructed PET distribution can be described by an integral 
transform, which, if the PSF is position-invariant, is called convolution. In principle, it is possible to 
reduce the severity of the PVEs by performing an inverse filtering or de-convolution operation on 
the reconstructed image (2, 3), or by using a resolution recovery technique during image 
reconstruction (4, 5). However, this type of methods cannot provide a full correction due to loss of 
high-frequency information from the measured PET data. In order to perform a more accurate 
correction for PVEs, it is necessary to introduce additional information, which can be obtained from 
high-resolution anatomical images, such as CT or MRI. A number of correction methods based on 
anatomical images have been developed in the past, although these are not in general being used 
routinely in clinical practice. Various reviews of PVC methods have been published previously (1, 6, 
7).  
In anatomically guided PVC methods, the anatomical image must, first of all, be co-registered with 
the PET image. Furthermore, most methods require that it be segmented into regions, which, for the 
purpose of the correction, can be assumed to contain a uniform distribution of activity. The result of 
the PVC is sensitive to errors in the co-registration and segmentation steps (8-10). The image co-
registration can be performed with a range of available software tools (11-13), but it obviously 
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becomes easier if the images have been acquired on a multi-modality system, such as PET/CT or 
PET/MRI (14, 15). With a PET/CT scanner, the CT scan and the PET data acquisition are actually 
performed sequentially, so there is a possibility of patient motion between the two. On the other 
hand, a PET/MRI scanner technically allows for truly simultaneous acquisition of PET and MRI data. 
Although co-registration may still be needed, the adjustment needed should be minimal and any 
residual errors small. With regards to segmentation, MRI is in general preferable to CT, as it has 
better soft-tissue contrast, which is especially important in brain studies. For these reasons, the 
recent introduction of PET/MRI scanners could greatly facilitate the use of PVC in routine clinical 
studies.  
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[Box 1] The partial volume effect 
Figure 1 shows results from a simulated NEMA-EIC phantom. The highest value in the largest 
spheres is correct in the noise-free case, but for the smaller spheres, the maximum value 
decreases as the diameter decreases. The true values in all the spheres can be restored by PVC.  
Figure 2 shows the max and mean values as a function of diameter. With noisy data, the max 
value gives over-estimation for the larger spheres and under-estimation for the smaller 
spheres, while the mean value gives under-estimation for all spheres and is much less sensitive 
to noise. 
 
 
 
 
 
 
  
Figure 1: Simulated phantom with 6 hot inserts. Left panel) Original phantom (a), 
reconstructed image without noise (b), and with noise, before (c), and after PVC with RBV (16) 
(d). Right panel) A circular profile through the centre of the spheres in the original phantom 
(blue line), and in the reconstructed image without noise (red line).  
 
Figure 2: Maximum (blue lines) and mean values (red lines) in the spherical inserts as a 
function of sphere-size for noise-free data (nf, solid lines) and data with noise (wn, dashed 
lines).   
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[Box 2] Clinical PVEs  
PVC can be important in situations when the PVEs change over time or between subjects, and 
could be a confounding factor in the interpretation of the PET images.  
In neurology studies of patients with Alzheimer’s disease, atrophy can lead to thinning of the 
cortical gray matter layer as compared to normal subjects (Fig. 3a). In cardiology studies, the 
thickness of the myocardial wall changes during the cardiac cycle, being thicker at end systole as 
compared to end diastole (Fig. 3b). In oncology studies, the size of a tumour can change after 
therapy (Fig. 3c).  
 
Figure 3: Schematic illustration of the effects of PVE in various clinical situations. a) Cortical 
thinning in a neurological study, leading to an apparent decrease in the tracer uptake. b) 
Cardiac contraction, leading to apparent increase in tracer concentration. c) A change in tumour 
size and tracer concentration, resulting in unchanged apparent mean concentration. In each 
panel, the top row shows the true tracer distribution, and the bottom row the PVE affected 
distributions. The left and right columns show anatomical changes occurring over time.  
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PVC methods  
The correction for PVEs based on anatomical data can be considered to fall into two main 
approaches; post-reconstruction methods and reconstruction-based methods. A brief historical 
overview of these methods is presented as well as a review of the findings for various clinical 
applications. Of the two main approaches, the post-reconstruction methods appeared first. Initially 
the correction was applied to the mean value for one or more volumes-of-interest (VOIs), and later 
voxel-by-voxel methods were developed. The next step was to incorporate anatomical information 
directly into the image reconstruction algorithm. It has been shown that the reconstruction-based 
methods can be superior in terms of bias vs. noise trade-off (17). On the other hand, the post-
reconstruction methods have the advantage of being easier to implement, and can be combined 
with the standard reconstruction software provided with the system. The historical evolution of the 
different methods is shown in Fig. 4.  
Post-reconstruction methods 
In 1979, Hoffman et al. (18) proposed a method to correct the mean value in an image region or VOI, 
assuming a uniform distribution within the VOI and no background activity. The corrected value was 
obtained by dividing the un-corrected mean value by a pre-calculated recovery coefficient (RC), 
which depended on the shape and size of the VOI and the system PSF. This method corrected for 
spill-out but not for spill-in. From here, multiple PVC methods evolved in different directions. RC-
based methods have often been used for PVC in oncology (19).  
Regional simultaneous estimation methods (A) 
A series of method were developed, based on the principle of simultaneously estimating the mean 
values in two or more regions by first calculating the RCs for all regions and the cross-talk 
coefficients for all combinations of regions, and then solving a system of linear equations. This 
approach corrected for both spill-in and spill-out. In 1983, Henze et al. (20) developed a PVC method 
for cardiac studies, with simultaneous estimation of the activity concentrations in the myocardial 
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wall and the ventricular cavity of the left ventricle. Four recovery/cross-talk coefficients were 
determined, based on the geometry of the heart and the system PSF, and the corrected mean values 
were obtained by solving a system of 2 linear equations with 2 unknowns, assuming no background 
activity. In 1998, Rousset et al. (21) presented a similar method for neurology, but with many more 
regions, covering the entire brain. A matrix of recovery/cross-talk coefficients was generated (the 
geometric transfer matrix (GTM)), and the corrected mean values of all regions were obtained by 
multiplying the inverse of this matrix with a column-vector containing the un-corrected mean values. 
This method is known as the GTM method. A similar method was presented by Labbé et al. (22). 
Here the image was modelled as the sum of a number of components, each one corresponding to a 
single region convolved with the system PSF, multiplied by un-known coefficients. The authors used 
singular value decomposition to determine the values of the coefficients, which represent the 
corrected mean values for the different regions, but other mathematical techniques could be used. 
For example, an alternative algorithm was presented by Sattarivand et al. (23). In 2005, Du et al. (24) 
described a perturbation-based method for calculating the matrix coefficients for the GTM method 
(21). This technique allows one to take into account the non-linearity of iterative reconstruction 
methods. Although developed for SPECT, it is also applicable to PET data.  
Voxel-based additive and multiplicative methods (B) 
In previous methods, the outcome was a corrected regional mean value, but in 1988, Videen et al. 
(25) proposed a PVC method for voxel-by-voxel correction. A single VOI was used, and RC-values 
were determined for each voxel within the VOI. The application was neurology and a VOI 
corresponding to brain-tissue was obtained by segmentation of a CT image. It corrected for spill-out 
but not for spill-in, assuming no background activity. Meltzer et al. (26) implemented this method, 
using MRI instead of CT images. Müller-Gärtner et al. (27) developed this method further by 
introducing a spill-in correction term. The brain was segmented into gray matter (GM), white matter 
(WM) and cerebro-spinal fluid (CSF), and the correction was applied to GM voxels only, including 
correction for spill-in from WM, assuming the true mean value in WM could be directly estimated. 
9 
 
Erlandsson et al. (28) proposed a method, combining the GTM technique for estimation of the VOI 
mean values, with a Müller-Gärtner-type approach for performing a voxel-based correction of each 
VOI. With this method, called multi-target correction (MTC), the entire image could be corrected on 
a voxel-by-voxel basis, and no prior information was required.  
Purely multiplicative methods (C) 
In 1984, Kessler et al. (29) extended the RC-method in order to take into account spill-in from 
activity in the background. Correction factors were determined for given target-to-background 
ratios, which simultaneously corrected for spill-in and spill-out. In order to find the right RC value to 
use, it is necessary to know the lesion size and the target-to-background ratio. Methods to 
determine this information directly from PVE-affected PET images were proposed by Gallivanone et 
al. (30). A voxel-based method for neurology was presented by Yang et al. in 1996 (31). This is a 
purely multiplicative method, which is applied to the entire image. The brain was segmented into 
GM, WM and CSF, and an assumption had to be made regarding the relative activity concentrations 
in the 3 regions. In 2011, Thomas et al. (16) presented a method called region-based voxel-wise 
correction (RBV), similar to MTC (28), in which the GTM method (21) was combined with the voxel-
based correction approach by Yang et al. (31). Erlandsson et al. (1) proposed an alternative 
algorithm, called “iterative Yang” (iY), in which the first step of RBV was replaced by an iterative 
procedure for estimation of the regional mean values, avoiding the GTM step.  
Wavelet-transform methods (D) 
In 2006, Boussion et al. (32) presented a novel approach for PVC, in which details from a high-
resolution anatomical image were integrated into a low-resolution PET (or SPECT) image in the 
wavelet domain. Wavelet coefficients from the anatomical image, corresponding to high spatial 
frequencies, were transferred to the PET image, after scaling by the ratio of the wavelet coefficients 
from the two images at a lower frequency. Shidahara et al. (33) presented an improved version of 
this method, in which the MRI image was first segmented and parcellated using an anatomical atlas. 
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When the method was evaluated using simulated dynamic PET data, the results showed improved 
quantification (34), and when applied to real clinical data, the results were comparable to those of 
the GTM method (35).  
Deconvolution methods (E) 
In 2010, Segobin et al. (36) presented an iterative deconvolution algorithm, combined with regional 
averaging based on a partially segmented anatomical image. This approach could be useful where 
reliable segmentation was possible for only part of the image. Bousse et al. (37) proposed a post-
reconstruction deconvolution technique, based on a maximum penalized likelihood algorithm, 
where the PET image is described by a model, assuming the existence of activity classes that behave 
like hidden Markov random fields, driven by a segmented MRI image. The method outperformed 
other post-reconstruction PVC methods when the segmented MRI was inconsistent with the PET 
image.  
Segmentation-free methods (F) 
In 2012, Wang & Fei (38) proposed a PVC method based on iterative deconvolution within a 
Bayesian framework, which included an edge-preserving smoothness constraint. The constraint was 
imposed using a neighbourhood structure, including voxels depending primarily on the difference in 
PET image values and secondly on the difference in MRI values. Yan et al. (39) also proposed a novel 
post-reconstruction method, which did not require segmentation of the MRI image. It was based on 
the assumption that a linear relationship exists between PET and MRI image intensities in a local 
neighbourhood around each voxel.  
Reconstruction-based methods 
Anatomical data can be incorporated into an iterative image reconstruction method as a priori 
information (or just “prior”) within a Bayesian framework. This means that the reconstruction 
algorithm is guided towards solutions, which have higher probability of being correct. This is known 
as a “maximum a posteriori“ (MAP) algorithm. An alternative is to use penalised likelihood 
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algorithms, although, in practice, the two approaches are quite similar. Traditionally, a smoothing 
prior would be used in order to limit the noise-amplification, often seen in iterative algorithms. 
However, this also results in resolution degradation. The role of the anatomical prior is to restrict the 
resolution degradation and preserve anatomical features in the image. The correction for PVE is 
achieved by modelling the PSF during the reconstruction process. We can distinguish between 
different types of prior; some utilise the spatial distribution of the anatomical image, some the 
image intensity.  
Spatial prior methods (G) 
In 1991, Chen et al. (40) presented a Bayesian reconstruction algorithm, incorporating anatomical 
boundary information from CT or MRI images. They achieved significant improvement in image 
quality with simulated data. Fessler et al. (41) propose a penalised likelihood reconstruction method 
with boundary information from MRI images, which took into account possible errors in the 
boundary information due to errors in the co-registration or segmentation. This was done by 
blurring the corresponding weights in the penalty term. Gindi et al. (42) proposed a Bayesian 
reconstruction method, which utilised an edge-map from an anatomical image, taking into account 
the uncertainty in the location of the edges by a spatially varying modulation of the probability. 
Ouyang et al. (43) presented a Bayesian reconstruction algorithm based on the joint probability of 
structural and functional boundaries. Boundary information was extracted from anatomical images, 
but only those boundaries which had high joint probability with the corresponding PET data were 
used. Chiao et al. (44) presented a penalised likelihood reconstruction algorithm with anatomical 
boundary information for cardiac perfusion studies, with co-registration parameters included in the 
optimisation process.  
In 1996, Ardekani et al. (45) proposed an anatomically guided reconstruction algorithm that did not 
require segmentation of the MRI image. It was based on the cross-entropy between the estimated 
PET image and a prior image model, obtained by edge preserving smoothing of the previous 
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estimate. The weights of the smoothing kernel were determined for each voxel, based on the 
difference in the MRI image values. Bowsher et al. (46) presented a Bayesian algorithm for 
reconstructing PET or SPECT images and, at the same time, segmenting them into a number of 
regions. Anatomical information was utilised by assigning higher prior probabilities to segmentations 
in which each segmented region stayed within a single anatomical region. Lipinski et al. (47) 
presented a Bayesian reconstruction method, which assumed that all voxels within an anatomical 
region have values belonging to a Gaussian distribution with a given mean value. The method 
resulted in images with low noise, but was sensitive to incomplete or erroneous anatomical 
information. Sastry and Carson (48) proposed a similar algorithm, in which a Gaussian distribution 
was assumed for different tissue types (GM, WM, CSF and “other”). Each voxel was modelled as 
being composed of the different tissue types in proportions determined by a segmented MRI image. 
Furthermore, a smoothness constraint was used for each separate tissue type.  
In 2002, Comtat et al. (49) presented a modified version of the algorithm proposed by Fessler et al. 
(41), in which the anatomical labels were blurred in order to take into account possible registration-
errors. Baete et al. (50) presented a MAP algorithm, for FDG brain studies. The MRI images were 
segmented into fuzzy classes corresponding to GM, WM, CSF and “other”. For the purpose of 
calculating spill-in to the GM region, the WM and CSF regions were assumed to be uniform. Bowsher 
et al. (51) proposed a segmentation-free approach for incorporating MRI information into the 
reconstruction process, similar to the one proposed by Ardekani et al. (45). An edge-preserving 
smoothing operation was used. The smoothing kernel was generated by choosing a subset of voxels 
within a neighbourhood, with the smallest difference in MRI values. In 2010, Vunckx et al. (52) 
described an improved version of this prior, which takes into account the fact that the voxel-
neighbourhoods selected are not symmetric.  
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Intensity prior methods (H) 
In 2000, Rangarajan et al. (53) introduced a novel Bayesian framework for incorporating anatomical 
information into emission tomographic reconstruction, which did not require that the anatomical 
and functional regions were exactly homologous. The algorithm used a prior based on the mutual 
information, calculated from the joint histogram for the two images. A segmented anatomical image 
was used. In 2005, Somayajula et al. (54) presented a segmentation-free algorithm, based on the 
mutual information between various image features in the PET and anatomical images. The 
algorithm was sensitive to local maxima, and it was necessary to start with a good initial estimate. 
Nuyts (55) compared two anatomically driven MAP reconstruction algorithms with priors based on 
mutual information and joint entropy of the image intensities, respectively. He found that the joint 
entropy prior was superior, although local maxima could lead to convergence problems. Tang and 
Rahmim (56) also developed a MAP reconstruction algorithm, with a joint entropy prior. Using 
simulated data, they obtained improved noise versus bias tradeoff even in a lesion in the PET image 
which had no anatomical correspondence.  
In 2010, Tang et al. (57) presented a method, which incorporated anatomical information into an 
algorithm for direct reconstruction of parameteric images from dynamic PET data. The method was 
based on a graphical analysis approach (58), and the anatomical information was incorporated using 
a joint entropy prior within a MAP algorithm. Pedemonte et al. (59) presented a MAP reconstruction 
algorithm with a prior based on class conditional joint entropy, in order to take into account the 
underlying tissue composition. The MRI was assumed to be composed of GM, WM, CSF and “other” 
with Gaussian distributed image intensities. The method outperformed conventional methods based 
on joint entropy. Somayajula et al. (60) described an approach with priors based on mutual 
information and joint entropy. Scale-space theory provided a framework for the analysis of images 
at different levels of detail, and presented a solution to the non-spatial nature of these measures. 
The scale-space features were defined as the original image, the image blurred at different scales, 
and the Laplacians of the blurred images. In 2015, Tang and Rahmim (61) developed a MAP 
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reconstruction algorithm with a joint entropy prior, in which local spatial information was 
incorporated using a wavelet decomposition. The algorithm performed better than a standard joint 
entropy MAP algorithm, based on image intensity only, in the case of noisy data.  
Diffusion prior methods (I) 
In 2009, Chan et al. (62) explored an alternative approach to incorporating an anatomical prior into 
PET image reconstruction, in particular for the situation where lesions are apparent in the emission 
images but not in the corresponding anatomical images. The proposed method was based on an 
anatomically adaptive anisotropic median-diffusion filtering prior. The proposed prior could yield 
improved lesion contrast and reduced bias without requiring knowledge of lesion outlines. 
Kazantsev et al. (63) proposed a penalised maximum-likelihood algorithm, incorporating an 
anatomically driven anisotropic diffusion filter, with edge-preserving de-noising characteristics, 
which has the ability to retain information that was absent in the anatomical image. 
A level set method (J) 
In 2011, Cheng-Liao and Qi (64) proposed an approach to MAP reconstruction of PET images with a 
level set prior guided by anatomical edges, which did not assume an exact match between PET and 
anatomical boundaries, but encourages similarity between the two.  
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Figure 4: The historical development of anatomically guided post-reconstruction PVC methods (left) 
and reconstruction-based methods incorporating anatomical data (right). (The letters A-J refer to 
corresponding sections in the text.)  
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Clinical applications of PVC 
PET/MRI offers clear advantages for partial volume correction. The ability to acquire anatomical 
information sequentially or even simultaneously to the acquisition of PET data helps alleviate many 
of the image registration issues that can be problematic with these correction techniques. 
Furthermore, the exquisite level of soft tissue contrast offers advantages to CT when it comes to 
feature definition, and can also give a better understanding of the tissue mix in PET voxels. The 
recent introduction of PET/MR as an imaging modality means that there is a dearth of literature on 
clinical partial volume correction on these scanners. The techniques discussed in the following 
section describe the application of partial volume methodologies to clinical PET data. Most of the 
methods described can be applied to PET/MR data, and also give an appreciation of the challenges 
that will be faced when applying such techniques to PET/MR studies. 
Cardiology 
In nuclear cardiology, there is a clear need for partial volume correction, although it is not commonly 
applied in clinical practice. For the assessment of myocardial blood flow, uptake of tracer is 
measured in tissue which has a thickness of around 15 mm in its systolic phase, and typically 
becomes much thinner in the diastolic phase. The resulting changes in partial volume losses can be 
visualised when viewing ECG-gated PET data. Apparent changes in blood flow are seen throughout 
the cardiac cycle, when in reality, for most patients the blood flow should be relatively stable. The 
problem becomes more of an issue when we also consider the radionuclides typically used for 
myocardial perfusion imaging in PET. 13N-ammonia, 15O-water, and 82Rb-chloride are three agents 
commonly used in myocardial perfusion imaging, with each emitting more energetic positrons than 
the frequently used 18F. Indeed 82Rb emits very energetic positrons, which, because of the longer 
positron path, leads to poorer spatial resolution than that typically seen in PET. The correction for 
changes in apparent blood flow across the cardiac cycle, and the relative difference between 18F and 
82Rb PET has been assessed in a paper by Johnson (65). To correct for the change in partial volume 
effects, the authors follow a two-step approach. In the first step the change in apparent uptake at 
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end-diastole compared to end-systole is assessed to calculate the relative difference in partial 
volume effects at the two phases. Then using phantom data with known thicknesses and partial 
volume losses, the correction for end-systole is determined, and from this the correction for end-
diastole is derived. Using the ECG-gated data to determine the amount of time spent in the diastolic 
and systolic phases, it is then possible to obtain average whole heart cycle partial volume correction 
factors for ungated images.  
The assessment of uptake in the myocardial tissue is not the only issue in myocardial perfusion 
imaging. Proper quantitative analysis of perfusion requires the use of kinetic modeling, which brings 
its own associated problems: the losses/spill-out of myocardial uptake into the surrounding areas 
including the ventricular cavities; and spill-in of activity into the myocardium from the ventricular 
cavities. While the latter is not too problematic at late time phases where blood pool activity is 
limited, at early and intermediate dynamic time frames there can be significant activity in the blood 
pool, and low but growing activity in the myocardium. This can be complicated further as a volume 
of interest in the ventricular cavity may be used as an image-derived input function for the kinetic 
modeling. One of the earliest PVC methods for myocardial imaging, suggested by Herrero (66), 
assumes a Gaussian point spread function representation of spatial resolution can be convolved with 
image data of known dimensions to estimate partial volume losses. The authors used a previously 
calculated value of the point spread function, an assumed thickness of myocardium, and 11C-
monoxide PET as a way of measuring the size of the ventricular cavity to calculate the partial volume 
losses in a series of dog studies. In a study by Iida (67), two methods of partial volume correction 
were evaluated for the correction of myocardial perfusion data. The first measurement involved the 
inclusion of a tissue fraction in the kinetic model of 15O-water data, whereas the other method used 
a combination of transmission scan imaging and 11C-monoxide imaging to produce images of 
extravascular density. Of course, these techniques are applied to dynamic data, with no regard given 
to the differences across the cardiac cycle.  
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In recent years there has been a plethora of software available to calculate myocardial blood flow 
(68), with several different methods used to deal with partial volume effects. Some of these 
solutions take a simple approach to minimise PVEs by assuming fixed global values of partial volume 
loss, and by using image derived input function volumes placed in positions with minimal spill-in 
effects from surrounding tissue. Other researchers have used generalised factor analysis of the 
dynamic data itself in an attempt to intrinsically correct for PVEs (69). An alternative approach which 
has become popular in commercialised software (70, 71) is that proposed by Hutchins et al. 1990 
(72). It assumes that if the blood to myocardium spill-over plus the tissue blood-fraction is equal to 
fb, then the myocardial activity contribution can be represented by 1-fb. This parameter can then be 
incorporated into the kinetic models to determine partial volume corrected kinetic parameters. This 
technique has since been modified further by using whole myocardium volumes of interest to 
reduce the spill-over effects into the image derived input function, which are in turn used to derive 
better regional values of myocardial blood flow (73).  
Oncology  
In oncology, the application of partial volume techniques in clinical use is more limited. In the most 
part, clinics report uptake in terms of maximum pixel value rather than the mean value in a 
region/tumour in an attempt to minimise the issues of partial volume losses. Of course, this is a 
primitive and rather limited solution because the region/tumour uptake is already likely to be 
affected by partial volume effects if it is small in size, and the reliance of a single maximum voxel 
value is also not robust. The introduction of SUV-peak, which looks at uptake in a group of pixels 
helps overcome the robustness to noise issues, but can still be affected by partial volume issues. 
There are also other issues to consider when introducing partial volume correction in oncology. Is 
correction required for a tumour volume, or for an image? Will the volume of interest be defined on 
the PET or corresponding anatomical image? Can the technique be easily applied and used in a busy 
PET clinic?  
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By the far the most common form of partial volume correction performed in oncology PET is the use 
of recovery coefficients. Assuming tumours are spherical in shape, and that their diameters can be 
determined, these methods use phantom measurements to predict the underestimation of uptake 
due to spill-out, and any spill-in of surrounding tissues. Adler et al. (74) was an early proponent of 
this method in the imaging of lymph nodes in breast imaging although spill-in effects were not 
considered. Avril et al. (75-77) expanded this method, again in breast cancer to look at different 
contrasts in phantoms and was thus indirectly looking at spill-in effects. Since these early attempts 
further refinements have been made. Vesselle et al. (78) working in lung cancer introduced a 
background region into the correction to deal with spill-in effects – something which is particularly 
important for small tumours. This approach was developed further by Hickeson et al. (79) who used 
very specific concentric background VOIs, and Hofheinz et al. (80) who developed a yet more 
complex method for background ROI determination. The Hofheinz technique has also been 
introduced into a clinical software platform to create a simple and automated approach to 
oncological partial volume correction with improved intra- and inter-operator error (81). Salavati et 
al. (82) applied this technique to FDG PET/CT studies of lung lesions with and with-out respiratory 
gating. They found that after PVC, SUVmean increased substantially, and that the PVE appeared to be 
the dominant source of quantitative error of lung malignancies. However, they found no clinically 
significant difference between respiratory-gated and non-gated data after PVC.  
When applying such partial volume corrections, these and other authors have found improvements 
in diagnostic performance or better correlation with other physiological metrics. The success of the 
recovery coefficient technique is based on its simplicity, although it does have its limitations. The 
assumptions that the tumour is spherical, and that its uptake is homogeneous are questionable, 
particularly for larger tumours that may also have necrotic centres. Another issue is the 
determination of the tumour radius. The higher spatial resolution CT component from PET/CT, or 
indeed the MRI component from PET/MRI systems can potentially help, but unfortunately the 
metabolic volume does not always correspond to the anatomical volumes that these modalities 
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offer. Defining tumour volumes based on PET has been attempted (79, 83), but the robustness of 
this technique has yet to be proven particularly in smaller lower contrast lesions. A final issue with 
recovery coefficient techniques is that the correction is performed on a volume and not on the 
image as a whole. This is generally not a problem in oncological PET, where the tumour uptake is 
typically the main output metric of interest, but this approach is not helpful when the general 
distribution of uptake or heterogeneity of uptake within a tumour is required.  
Other partial volume techniques in oncological PET are more complex, and because of this only 
appear in proof of concept studies with small patient numbers (32, 84, 85). An approach that has 
gained some interest is the use of deconvolution using Van Cittert (2) or Lucy-Richardson techniques 
(86) to iteratively recover resolution losses across an image. One problem with these methods is that 
noise can be amplified using these approaches, although de-noising using e.g. a wavelet 
methodology has been applied with good results (86, 87). Another issue with deconvolution 
techniques is that they are dependent on an accurate measurement of spatial resolution (point-
spread function). Because spatial resolution changes across the PET field of view, this can be difficult 
to model. This issue affects other PVC methods as well, but it is more critical for deconvolution 
techniques, as no other information is utilised.  
The wide choice of partial volume correction algorithms leads to difficulty in choosing the most 
appropriate algorithm for oncological imaging. In PET, although accuracy is important, because many 
patients are assessed longitudinally for treatment response and/or disease progression, test-retest 
reproducibility is equally important. Hoetjes et al. (83) evaluated three approaches of partial volume 
correction for accuracy and reproducibility in simulated and patient data. The study compared an 
iterative deconvolution approach, correction as part of iterative reconstruction, and a mask-based 
approach, and found reconstruction-based PVC performed best, although each of the other two 
approaches were adequate and easy to implement alternatives. Of course, it is assumed that PVC 
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provides improved quantitative performance. Although this may be the case, it does not necessarily 
lead to improved diagnostic outcomes (87, 88).  
Neurology 
In PET, the widest use of partial volume correction techniques is seen in neurological applications. 
The size and thickness of areas of interest in the brain together with the relative ease of image 
segmentation and image registration have led to a plethora of literature describing various 
methodologies and their clinical application. Since its initial conception and application in 11C-
carfentanil PET by Meltzer et al. (26), a simple segmentation approach of dealing with atrophy 
related signal losses has been popular. Ibáñez et al. (89) used the method to show that hypo-
metabolism as seen in FDG PET is a real phenomena, and not something caused by cortical atrophy 
related signal loss. Following on from this, Meltzer et al. (90) and Ibáñez et al. (91) using the same 
technique also found that apparent reductions in cortical glucose metabolism with increasing age 
were not real, but actually caused by normal age related increases in cortical atrophy. Refinements 
to the Meltzer technique have also been developed. Adapting the approach to include a spatially 
variant PSF, Labbé et al. (92) applied their technique in the analysis of 4 control and 8 Alzheimers 
disease patients imaged using 18F-FDG PET. However, the most popular variant of the original 
Meltzer method, which replaced a single brain tissue compartment with individual grey and white 
matter compartments was that proposed by Müller-Gärtner et al. (27). Giovacchini et al. (93), using 
dynamic imaging of 8 young and 7 old subjects confirmed with the application of both Meltzer and 
Müller-Gärtner methods that blood flow was not affected by healthy ageing. Conversely, looking at a 
different biomarker, Bencherif et al. (94) imaging 14 healthy control subjects with 11C-carfentanil 
showed an age effect in uptake with partial volume correction, which disappeared when no 
correction was applied. In turn, the Müller-Gärtner method has also seen slight revisions (95) which 
have been applied in an FDG PET aging study (96). The relative advantages of two (Meltzer) or three 
(Müller-Gärtner) segmentations has also been explored (97). Although three segmented 
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compartments lead to slightly higher accuracy, they can be less robust than two compartments due 
to the mis-registration and segmentation errors that can prove problematic for these techniques.  
There are also other PVC techniques that have been applied to clinical data. Goffin et al. (98) found 
benefits in applying anatomical based prior MAP reconstructions to reduce partial volume effects, 
when trying to localise focal cortical dysplasias in epileptic patients imaged with FDG. While in the 
area of Alzheimer’s disease, Thomas et al. (16) compared the Van-Cittert and RBV method together 
with the Müller-Gärtner method in a series of 70 amyloid PET scans, with the RBV method 
performing best out of the three methods. Another commonly used method of partial volume 
correction in neurological PET is the GTM method (21). In 2008, Rousset et al. (99) applied this 
method to 90 11C-raclopride studies of healthy volunteers, showing increased and also less 
heterogeneous uptake (in terms of caudate vs. putamen) when compared to uncorrected studies.  
The application of PVC techniques is becoming more widely reported in clinical dementia 
populations, where atrophy is clearly a common issue. Drzezga et al. (100) used commercialised 
Müller-Gärtner PVC software for correction of 11C-PIB and FDG studies of patients with Alzheimer’s 
disease and semantic dementia. The same group also used the technique in a longitudinal study of 
15 patients, again with 11C-PIB and FDG in an attempt to follow the changes in Alzheimers disease 
over a period of two years (101). Further longitudinal amyloid PET studies by Su et al. (102) with the 
GTM method and Meltzer method, and Brendel et al. (103) using just the GTM method have also 
recommended the use of partial volume correction in these types of studies, with the GTM providing 
slightly better results than the Meltzer method. 
Once more, one of the concerns with applying these techniques in longitudinal studies is the test-
retest reproducibility of these methods with issues typically arising from errors in image registration 
and segmentation. In the study by Su et al. (102), segmentation errors led to test-retest variability of 
around 1.5%, which compared well to the 2% errors from the volumes of interest used to derive 
regional uptake. However it would appear that the use of different segmentation algorithms can 
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lead to different results in the same patients, suggesting that segmentation algorithms are not 
interchangeable when performing partial volume correction (9, 10). Nevertheless, the recent swell in 
the use of partial volume correction in dementia PET studies suggests that partial volume correction 
may become mainstream in these studies. See box 3 for a clinical example.  
Vascular 
Beyond the derivation of corrected image derived input functions in vessels (see article by Lepage in 
this issue), there have also been studies looking at correcting uptake in features within the vessel 
itself. Izquierdo-Garcia et al. (104) used a GTM methodology to correct uptake in plaques in 7 
patients imaged with FDG and found corrected data to be both accurate and reproducible in the 
carotid artery wall. Reeps et al. (105) looked at performing partial volume correction in abdominal 
aortic aneurysms in 23 patients undergoing FDG PET imaging. Using a novel approach which created 
a geometric model of the area of interest, and a factor that accounted for the spatial resolution of 
the PET system, the study found that partial volume correction was not mandatory for such imaging, 
but may provide a role in helping to stratify patients. Burg et al. (106) compared various methods for 
quantifying tracer uptake in the aortic vascular wall in 18FDG PET studies using simulations based on 
an anthropomorphic digital phantom. They found that PVC using the GTM method gave the most 
reproducible results, although some bias remained due to the low dimensions of the vascular wall. 
Blomberg et al. (107) evaluated the impact of a novel PVC method, based on contrast-enhanced CT 
data, on quantification of arterial wall 18F-FDG uptake. The PVC method used was similar in principle 
to the Hofheinz method (80). Their study showed that PVC significantly influences quantification of 
arterial wall 18F-FDG uptake. On the other hand, they also found a good correlation between the 
values before and after PVC at 180 min post-injection, and concluded that the un-corrected values 
could be used as a measure of arterial 18F-FDG uptake (107).  
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[Box 3] Clinical example – neurology 
Figure 5 shows images from a clinical study on a patient with semantic dementia and left 
temporal lobe atrophy. PET studies were performed with two different tracers: 18F-FDG for 
glucose metabolism, and the amyloid tracer 18F-AV45. Images are shown without PVC and with 
PVC using the iterative Yang method. (1) The two tracers have different distributions. The AV45 
scan was amyloid negative, with mainly non-specific uptake in WM, while the FDG study shows 
mainly uptake in GM.  
 
 
  
 
  
 
 
 
Figure 5: Data from a clinical study with 18F-FDG and 18F-AV45 on the same patient, including un-
corrected FDG study (1st row), uncorrected AV45 study (2nd row), segmented/parcellated MRI scan 
(3rd row), corrected FDG study (4th row) and corrected AV45 study (5th row), with sagittal (left 
column), transaxial (middle column) and coronal (right column) sections. Each image volume was 
normalized independently.  
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Discussion 
There is increasing evidence that PVC is necessary in order to guarantee quantitative accuracy in 
emission tomography but there is reluctance to apply PVC routinely in clinical practice where there 
continues to be reliance on visual interpretation for many routine studies. There continues to be 
uncertainty by many clinicians regarding the method of choice and the absence of widely accepted 
and validated commercial software does little to encourage more widespread use. There also 
continues to be concern regarding the various potential sources of error (e.g. Frouin et al. (8)). Most 
PVC methods rely on having accurately registered anatomical data (preferably MRI) but the lack of 
ready availability of these data and historical problems with cross-vendor compatibility have been 
barriers to routine use; the availability of PET/MRI systems certainly removes (or at least reduces) 
these barriers. As mentioned earlier registration is not entirely guaranteed with PET/MRI but the 
degree of mis-registration is certainly reduced and non-rigid registration is unlikely to be needed. Of 
course the underlying assumption in many PVC methods is that the anatomical edge information 
matches the tissue boundaries underlying the functional or molecular image, which is not 
necessarily the case (e.g. there may be cellular invasion of tissues not visible in the anatomical 
image). Note also that non-rigid registration between high resolution MRI and the limited resolution 
PET can attempt to align identified edges in a way that invalidates the PVC procedure. There are 
similar concerns regarding segmentation approaches that are often necessary, especially where 
structures are very small (e.g. blood vessels). A small error in segmentation may represent a sizeable 
percentage error in estimated volume, and hence a significant source of error. Approaches that 
avoid the need for segmentation may be preferred, for example techniques that utilise local 
variation in MR contrast directly (39, 45, 51).  
In some cases it can be argued that PVC makes little difference to interpretation or indeed can have 
a negative influence due to enhanced noise. However, in situations where volume is changing in 
serial studies, misinterpretation is very common. Also if activity distribution changes in time, as is 
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clearly the case in kinetic studies, there can be significant errors introduced by PVEs. Take the 
example of a dynamic cardiac study where activity is initially circulating in the blood with significant 
spillover to the myocardium but later may be concentrated in the myocardium itself. Variation in the 
spillover will clearly affect the resulting time activity curves for both the ventricle (and image-derived 
input function) and myocardium, affecting any derived kinetic parameters. A recent paper by Su et 
al. (102) highlights the importance of performing PVC in kinetic amyloid studies which are being used 
to further elucidate uptake patterns in patients with dementia. Other groups have also shown the 
importance of PVC for kinetic analysis (8, 108, 109). PVC is also important for accurate estimation of 
image derived input functions (110). Further information on this topic can be found in the article by 
Lepage in this issue.  
An aspect of PV correction less commonly addressed is the influence of the ‘tissue fraction’ effect, in 
general this accounts for the uptake of tracer in selected targets contained within a voxel (e.g. 
uptake in the cellular matrix rather than blood or air in the lung). In fact heterogeneous uptake of 
tracer is invariably the case within the volume of tissue contained in a typical image voxel. Kinetic 
analysis often does take into account a vascular component but again problems arise if the non-
target tissue fraction varies spatially or temporally. Research on methods to tackle this problem, 
specifically applicable to lung studies, has been published (Lambrou et al. (111), Holman et al. (112)). 
This work relies on identifying air fraction from CT density and/or blood fraction based on kinetic 
analysis as a basis for deriving tissue fraction corrected values which may provide better indices of 
the underlying mechanism of uptake in disease or treatment response during therapy.  
There is a distinct shortage of published work on the direct comparison of different PVC methods. 
Validation is not a trivial exercise as it requires ground truth knowledge of tracer distribution which 
is not possible in vivo. Comparison of discrimination power is commonly used to justify choice of 
individual methods although in practice the effect can be small (e.g. Thomas et al. (16)). The 
alternative approach is based on simulation. The challenge is to implement simulation methods that 
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are clinically realistic, that use analysis techniques that are independent of the methods used for 
PVC and that provide meaningful metrics for comparative purposes. Ideally test datasets should be 
made openly available so that PVC can be tested by individual developers, in much the same way as 
the clinical datasets made available for evaluation through ADNI (113).  Development of such a 
library has been the aim of work undertaken in conjunction with the EU COST project (TD1007) with 
suggested approaches and preliminary results published by Hutton et al. (114) and Thomas et al. 
(115).  
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